Treatment of patients with primary antibody deficiencies in Germany;Behandlung von patienten mit primären antikörpermangelsyndromen in Deutschland

Klinische Padiatrie

Volumn 217, Issue 5, 2005, Pages 276-280

  Borte, Michael ^a   Oertelt, C ^b   Hogy B ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Germany; Intravenous immunoglobulins; Primary antibody deficiency; Subcutaneous immunoglobulins; Substitution therapy

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CHILD; DIAGNOSTIC TEST; GERMANY; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; MAJOR CLINICAL STUDY; SUBSTITUTION THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; GERMANY; HUMANS; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INJECTIONS, SUBCUTANEOUS; INTERVIEWS; OUTPATIENTS; PRACTICE GUIDELINES; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS;

EID: 25844447640     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-820297     Document Type: Article

References (11)

1. Andersen V, Franke K, Erkel J, Schindel F, Högy B. Subkutane IGG-Infusion bei Patienten mit primärem Immundefekt - eine retrospektive Fallsammlung. Mitt Bayer Ges Immun Tropenmed Impfwesen 2001; 18 (Sonderausgabe III): 14-17
2. Bruton OC. Agammaglobulinemias. Pediatrics 1952; 9: 722-727
3. Chapel H, Haeney M, Misbah S, Snowden N. Immunodeficiency In: Clinical Immunology. 4th ed. Blackwell Science, London 1999
4. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency. Clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48
5. Eijkhout HW et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. Ann Int Med 2001; 135: 165-174
6. Gardulf A, Andersen V, Björkander J et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 1995; 345: 365
7. Gardulf A, Hammarström L. Subcutaneous administration of immunoglobulins - What are the advantages? Clin Immunother 1996; 6: 108-116
8. IDF. Primary immune deficiency diseases in America. The first national survey of patients and specialists. www.primaryimmune.org/ patient%20survey%20publication.pdf
9. Lories RJU, Maertens JA, Ceuppens JL, Peetermans WE. The use of polyclonal intravenous immunoglobulins in the prevention and treatment of infectious diseases. Acta Clinica Belgica 2000; 55: 163-169
10. Schwartz SA. Intravenous immunoglobulin treatment of immunodeficiency disorders. Ped Clin North America 2000; 47: 1355-1369
11. Sorensen RU, Moore C. Antibody deficiency syndromes. Ped Clin North America 2000; 47: 1225-1252